Session 11 – From Precision Medicine to Precision Health
Date: 24 July (Friday) 10:40 – 12:10 (GMT+8)
Venue: 701EF, 7F, TaiNEX2 / Online event platform
Dr Damian Marshall is the Director of New Technologies at the Cell and Gene Therapy Catapult and has almost 20 years of industrial experience in ATMP development working for SME’s and large companies. He leads a team of ~70 scientist who collaborate with a wide range of cell and gene therapy companies to integrate innovative technologies to improve the manufacture of viral vectors and cell-based therapies. The team also focusses on high content analytics for product characterisation and has established a leading position in the integration of Process Analytical Technologies (PAT) for advanced bioprocess control.
Speech title & Synopsis